Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07135895 · ClinicalTrials.gov registry record · NA
The ArtixASCEND Study
A NA study of Acute Lower Limb Arterial Occlusion, sponsored by Inari Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 5
- Study locations
NCT07135895 is a NA study of Acute Lower Limb Arterial Occlusion that is actively recruiting participants, run by Inari Medical. The registered enrollment target is 250 participants. The trial reports 5 study locations across 5 states.
The verdict
NCT07135895, a NA study of Acute Lower Limb Arterial Occlusion, is actively recruiting participants, sponsored by Inari Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 5
- Study locations
Study Summary
This study is a post-market, prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the Artix Thrombectomy System in patients with acute lower extremity arterial occlusions.
Conditions Studied
Interventions
- DEVICE Artix Thrombectomy System
Study Locations (5)
Connecticut
- Yale University - New Haven
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
North Carolina
- Mission Memorial Hospital - Asheville
Oklahoma
- Ascension St. John Jane Phillips Medical Center - Bartlesville
South Carolina
- Grand Strand Medical Center - Myrtle Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2026-01-07 |
| Est. Completion | 2029-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07135895
The ClinicalTrials.gov registry entry for NCT07135895 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inari Medical, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Lower Limb Arterial Occlusion appearing as the primary indexed condition, and to 1 intervention - of which Artix Thrombectomy System is the first listed.
NCT07135895 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Connecticut, District of Columbia, North Carolina.
Frequently Asked Questions
What is clinical trial NCT07135895 about?
NCT07135895 is a clinical study titled "The ArtixASCEND Study". This study is a post-market, prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the Artix Thrombectomy System in patients with acute lower extremity arterial occlusions.
What is the current status of trial NCT07135895?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2026-01-07. Estimated completion is 2029-10-01.
What conditions does trial NCT07135895 study?
This clinical trial studies the following conditions: Acute Lower Limb Arterial Occlusion.
What interventions are being tested in trial NCT07135895?
The interventions under investigation include: Artix Thrombectomy System (DEVICE).
Who is sponsoring clinical trial NCT07135895?
This trial is sponsored by Inari Medical, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07135895 being conducted?
This trial has 5 study locations across Connecticut, District of Columbia, North Carolina, Oklahoma, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.